loadpatents
name:-0.017411947250366
name:-0.010764122009277
name:-0.0019028186798096
OH; Yu-Kyoung Patent Filings

OH; Yu-Kyoung

Patent Applications and Registrations

Patent applications and USPTO patent grants for OH; Yu-Kyoung.The latest application filed is for "biocompatible photothermal composition for treatment of cancer and skin diseases".

Company Profile
1.11.15
  • OH; Yu-Kyoung - Seoul KR
  • Oh; Yu-Kyoung - Gangnam-gu KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biocompatible Photothermal Composition For Treatment Of Cancer And Skin Diseases
App 20200384110 - OH; Yu-Kyoung ;   et al.
2020-12-10
Irinotecan-loaded dual-reverse thermosensitive hydrogel composition
Grant 10,172,943 - Choi , et al. J
2019-01-08
Irinotecan-loaded Dual-reverse Thermosensitive Hydrogel Composition
App 20180147282 - CHOI; Han-Gon ;   et al.
2018-05-31
Baculovirus-based vaccines
Grant 9,555,091 - Kim , et al. January 31, 2
2017-01-31
Pharmaceutical composition for treating cancer
Grant 9,217,149 - Won , et al. December 22, 2
2015-12-22
Baculovirus-based Vaccines
App 20150030621 - KIM; Young-Bong ;   et al.
2015-01-29
Pharmaceutical Composition For Treating Cancer
App 20140371300 - Won; Misun ;   et al.
2014-12-18
Pharmaceutical composition for treating cancer
Grant 8,846,630 - Won , et al. September 30, 2
2014-09-30
Chitosan based polymer conjugate and a method for producing the same
Grant 8,431,543 - Park , et al. April 30, 2
2013-04-30
Composition for treatment of cervix cancer
Grant 8,377,899 - Shin , et al. February 19, 2
2013-02-19
Pharmaceutical Composition For Treating Cancer
App 20130028957 - Won; Misun ;   et al.
2013-01-31
Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid
Grant 8,318,856 - Oh , et al. November 27, 2
2012-11-27
Uses Of Apoptotic Cell-targeting Peptides, Label Substances And Liposomes Containing A Therapeutic Agent For Preventing, Treating Or Therapeutically Diagnosing Apoptosis-related Diseases
App 20120258038 - Lee; Byung-Heon ;   et al.
2012-10-11
Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same
App 20120021044 - Oh; Yu-Kyoung ;   et al.
2012-01-26
Nucleic-acid Pharmaceutical Composition For Cancer Therapy
App 20110160282 - Oh; Yu-Kyoung ;   et al.
2011-06-30
Baculovirus-Based Vaccines
App 20100285056 - Kim; Young-Bong ;   et al.
2010-11-11
Composition Of Cationic Phospholipid Nanoparticles For Effective Delivery Of Nucleic Acids
App 20100203112 - Oh; Yu-Kyoung ;   et al.
2010-08-12
Pharmaceutical composition for treating cancer
Grant 7,745,419 - Oh , et al. June 29, 2
2010-06-29
Delivery system for nucleic acids using cationic polymer conjugates
App 20100144035 - Oh; Yu-Kyoung ;   et al.
2010-06-10
Chitosan Based Polymer Conjugate and a Method for Producing the Same
App 20100113559 - Park; Myung-Ok ;   et al.
2010-05-06
Composition For Treatment Of Cervix Cancer
App 20100062051 - Shin; Young Kee ;   et al.
2010-03-11
Pharmaceutical Composition For Treating Cancer
App 20090081282 - OH; Yu-Kyoung ;   et al.
2009-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed